logo

For the Inventor, By the Inventor

Merion, PA, United States of America

Amos B Smith, Iii

USPTO Granted Patents = 45 

 

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 142(Granted Patents)


Company Filing History:

goldMedal42 out of 2,597 
 
University of Pennsylvania
 patents
silverMedal2 out of 15,475 
 
University of California
 patents
bronzeMedal2 out of 1,209 
 
Dana-farber-cancer Institute Inc.
 patents
4. 2 out of 13 
 
Bryn Mawr College
 patents
5. 1 out of 224 
 
University Patents, Inc.
 patents
6. 1 out of 1 
 
Acidophil, LLC
 patent
7. 1 out of 20 
 
Val-chum, Limited Partnership
 patents
8. 1 out of 3,687 
 
Johns Hopkins University
 patents
9. 1 out of 2,489 
 
Columbia University
 patents
10. 1 out of 50 
 
Monell Chemical Senses Center
 patents
11. 1 out of 110 
 
Kosan Biosciences Incorporated
 patents
12. 2 out of 832,843 
Other
 patents
where one patent can have more than one assignee

Years Active: 1983-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
HIV-1 Inhibitors
Microtubule Stabilizers
Peptide Stapling
Neurodegenerative Treatments
Silicon-Based Coupling Agents
CD4 Mimetics
Dicarbonyl Compounds
Polypyrrolinone Synthesis
Thromboxane Receptor Antagonists
Peptidomimetics
Macrocycle Preparation
Triazole Derivatives
45 patents (USPTO):Explore Patents
1. 12286401 - Small molecules that sensitize HIV-1 infected cells to antibody dependent cellular cytotoxicity (2025-04-29),
2. 11623927 - Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules (2023-04-11),
3. 9975848 - Inhibitors of HIV-1 entry and methods of use thereof (2018-05-22),
4. 9850469 - Methods of stapling and unstapling peptides and proteins (2017-12-26),
5. 9850261 - Silicon-based cross coupling agents and methods of their use (2017-12-26),
6. 9776963 - Small molecule CD4 mimetics and uses thereof (2017-10-03),
7. 9649317 - Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies (2017-05-16),
8. 9643919 - Cycloalkyl-dione derivatives and methods of their use (2017-05-09),
9. 9540355 - Irciniastatin analogues (2017-01-10),
10. 9499660 - Silicon-based cross coupling agents and methods of their use (2016-11-22),
11. 9403763 - CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof (2016-08-02),
12. 8957097 - Hemi-phorboxazole A derivatives and methods of their use (2015-02-17),
13. 8927586 - Thromboxane A2 (TP) receptor antagonists (2015-01-06),
14. 8586632 - Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds (2013-11-19),
15. 8530520 - Cycloalkyl-dione derivatives and methods of their use (2013-09-10),

Title: Inventor Amos B Smith, III

Introduction: Amos B Smith, III is a renowned inventor based in Merion, Pennsylvania. He has made significant contributions to the field of innovation through his groundbreaking work in various patents.

Latest Patents: Amos B Smith, III holds several recent patents in the areas of chemical engineering and pharmaceuticals, showcasing his ongoing commitment to advancing technology and science.

Career Highlights: With a distinguished career spanning several decades, Amos B Smith, III has established himself as a leading figure in the world of inventors. His innovative solutions have revolutionized the industry and earned him widespread recognition.

Collaborations: Throughout his career, Amos B Smith, III has collaborated with top research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in the success of many groundbreaking projects.

Conclusion: In conclusion, Amos B Smith, III's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in Merion, PA, and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…